American Journal of Obstetrics & Gynecology
Volume 201, Issue 5 , Pages 482.e1-482.e8 , November 2009

Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study

  • Arnon Wiznitzer, MD

      Affiliations

    • Department of Obstetrics and Gynecology, Soroka University Medical Center, Ben-Gurion University of the Negev, Be'er-Sheva, Israel
    • ,
  • Amit Mayer, MD

      Affiliations

    • Department of Obstetrics and Gynecology, Soroka University Medical Center, Ben-Gurion University of the Negev, Be'er-Sheva, Israel
    • ,
  • Victor Novack, MD, PhD

      Affiliations

    • Faculty of Health Sciences, Soroka University Medical Center, Ben-Gurion University of the Negev, Be'er-Sheva, Israel
    • Harvard Clinical Research Institute, Boston, MA
    • Corresponding Author InformationReprints: Victor Novack, MD, PhD, Harvard Clinical Research Institute, 930 Commonwealth Ave., Boston, MA 02215
    • ,
  • Eyal Sheiner, MD, PhD

      Affiliations

    • Department of Obstetrics and Gynecology, Soroka University Medical Center, Ben-Gurion University of the Negev, Be'er-Sheva, Israel
    • ,
  • Harel Gilutz, MD

      Affiliations

    • Department of Cardiology, Soroka University Medical Center, Ben-Gurion University of the Negev, Be'er-Sheva, Israel
    • ,
  • Atul Malhotra, MD

      Affiliations

    • Divisions of Pulmonary and Critical Care and Sleep Medicine, Brigham and Women's Hospital, Boston, MA
    • ,
  • Lena Novack, PhD

      Affiliations

    • Faculty of Health Sciences, Soroka University Medical Center, Ben-Gurion University of the Negev, Be'er-Sheva, Israel
    • Harvard Clinical Research Institute, Boston, MA

Received 11 January 2009 ,Revised 31 March 2009 ,Accepted 18 May 2009.

References 

  1. Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. JAMA. 2005;294:2751–2757
  2. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?. BMJ. 2002;325:157–160
  3. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest. 2005;115:485–491
  4. Hollander MH, Paarlberg KM, Huisjes AJ. Gestational diabetes: a review of the current literature and guidelines. Obstet Gynecol Surv. 2007;62:125–136
  5. Frishman WH, Veresh M, Schlocker SJ, Tejani N. Pathophysiology and medical management of systemic hypertension in preeclampsia. Curr Hypertens Rep. 2006;8:502–511
  6. Kaaja R, Tikkanen MJ, Viinikka L, Ylikorkala O. Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol. 1995;85:353–356
  7. Ogura K, Miyatake T, Fukui O, Nakamura T, Kameda T, Yoshino G. Low-density lipoprotein particle diameter in normal pregnancy and preeclampsia. J Atheroscler Thromb. 2002;9:42–47
  8. Ray JG, Diamond P, Singh G, Bell CM. Brief overview of maternal TGs as a risk factor for pre-eclampsia. BJOG. 2006;113:379–386
  9. Sattar N, Bendomir A, Berry C, Shepherd J, Greer IA, Packard CJ. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol. 1997;89:403–408
  10. Mazurkiewicz JC, Watts GF, Warburton FG, Slavin BM, Lowy C, Koukkou E. Serum lipids, lipoproteins and apolipoproteins in pregnant non-diabetic patients. J Clin Pathol. 1994;47:728–731
  11. Sattar N, Greer IA, Louden J, et al. Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma TG on appearance of small, dense low density lipoprotein. J Clin Endocrinol Metab. 1997;82:2483–2491
  12. Desoye G, Schweditsch MO, Pfeiffer KP, Zechner R, Kostner GM. Correlation of hormones with lipid and lipoprotein levels during normal pregnancy and postpartum. J Clin Endocrinol Metab. 1987;64:704–712
  13. Llurba E, Casals E, Dominguez C, et al. Atherogenic lipoprotein subfraction profile in preeclamptic women with and without high TGs: different pathophysiologic subsets in preeclampsia. Metabolism. 2005;54:1504–1509
  14. Ziaei S, Bonab KM, Kazemnejad A. Serum lipid levels at 28-32 weeks gestation and hypertensive disorders. Hypertens Pregnancy. 2006;25:3–10
  15. Endresen MJ, Lorentzen B, Henriksen T. Increased lipolytic activity and high ratio of free fatty acids to albumin in sera from women with preeclampsia leads to TG accumulation in cultured endothelial cells. Am J Obstet Gynecol. 1992;167:440–447
  16. Lorentzen B, Drevon CA, Endresen MJ, Henriksen T. Fatty acid pattern of esterified and free fatty acids in sera of women with normal and pre-eclamptic pregnancy. BJOG. 1995;102:530–537
  17. Kaaja R, Laivuori H, Laakso M, Tikkanen MJ, Ylikorkala O. Evidence of a state of increased insulin resistance in preeclampsia. Metabolism. 1999;48:892–896
  18. Edison RJ, Berg K, Remaley A, et al. Adverse birth outcome among mothers with low serum cholesterol. Pediatrics. 2007;120:723–733
  19. Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002

 Cite this article as: Wiznitzer A, Mayer A, Novack V, et al. Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study. Am J Obstet Gynecol 2009;201:482.e1-8.

 The first 2 authors contributed equally.

PII: S0002-9378(09)00540-7

doi: 10.1016/j.ajog.2009.05.032

American Journal of Obstetrics & Gynecology
Volume 201, Issue 5 , Pages 482.e1-482.e8 , November 2009

Article Tools

* Image Usage & Resolution